- Joined
- Oct 19, 2006
- Messages
- 219
- Reaction score
- 210
Agree with your sentiments. We will tracking all our outcomes on a prospective registry study (same one at OSU).This is where how you practice will have such a big impact on your legacy.
If you put forward the resources (or better yet, convinced a third party to do so), run this practice from a business plan and market directly to desperate patients, you will (contingent on demographics/payors) make a sh!% ton of money...and no one will know if you did good by your patients in aggregate (sort of like chiropractic). These are conditions where subjective outcomes are important and are hard to measure. I have no doubt that you will have patients thanking you for your care.
But...this is much more dangerous tool than a set of hands (not entirely benign either). It also is high cost. 4% significant toxicity in the brain is serious. This is not 3 Gy over 6 fractions to a joint with a complex plan.
It would be nice if you found a way to contribute scientifically from an independent practice if you are taking on cases like this.
Curious as to why you couldn't carve out a practice directed at indications like this at a place like the James?
No procedure is risk free, and being able to manage your own complications is critical in niche foci. But If you examine the SRS outcomes compared to MRgFUS for ET, our toxicities is much lower. Efficacy is same or better at 1 year, but takes SRS a little longer to get there
I do this enough that I see the 4% complication rate, and we are leveraging radiomic patterns to predict and intervene on hyperresponders earlier.
I did carve this out at OSU and had the support of and great collaborators in the Neurosurgery department, but can’t do any more gray winters.